Report Feature
The future of the global upstream bioprocessing market looks promising with opportunities in biopharmaceutical manufacturing companies and research organizations. The global upstream bioprocessing market is expected to grow with a CAGR of 12%-14% from 2020 to 2025. The major drivers for this market are increasing prevalence of chronic diseases, rising research activities for development of biosimilars/biomolecules, small therapeutic peptide and monoclonal antibodies, and growing demand for process optimization and contamination free, safe and efficient production of biomolecules.
A total of XX figures / charts and XX tables are provided in this more than 150 pages report to help in your business decisions. Sample figures with some insights are shown below. To learn the scope, benefits, companies researched, and other details of the global upstream bioprocessing market report, please download the report brochure.
In this market, bioreactors is the largest product type of upstream bioprocessing, whereas multi-use is the largest use type. Growth in various segments of the upstream bioprocessing market are given below:
The study includes trends and forecast for the global upstream bioprocessing market by product, workflow, use type, mode, and region as follows:
By Product [Value ($ Million) shipment analysis for 2014 – 2025]:
- Cell Culture Products
- Bioreactors/Fermenters
- Filters, Bags & Containers
- Bioreactor Accessories and Others
By Workflow [Value ($ Million) shipment analysis for 2014 – 2025]:
- Cell Culture
- Media Preparation
- Cell Separation
By Use Type [Value ($ Million) shipment analysis for 2014 – 2025]:
- Single-Use
- Multi-Use
By Mode [Value ($ Million) shipment analysis for 2014 – 2025]:
- Outsourced
- In-House
By Region [Value ($ Million) shipment analysis for 2014 – 2025]:
-
North America
- United States
- Canada
- Mexico
-
Europe
- United Kingdom
- Germany
- France
-
Asia Pacific
- China
- India
- Japan
-
The Rest of the World
- Brazil
Some of the upstream bioprocessing companies profiled in this report include Thermo Fisher Scientific, GE Healthcare, Merck, Corning, Sartorius, Eppendorf, Applikon Biotechnology, Lonza, PBS Biotech, and CellGenix.
Lucintel forecasts that the bioreactors/fermenters will remain the largest segment over the forecast period due to its increasing demand in large as well small-scale bioproduction and development of automated bioreactors for safe, cost-effective, and regulatory-compliant manufacturing of cell-based products for clinical applications.
Within this market, multi-use will remain the largest segment by use type over the forecast period, as it is environment friendly and imposes lower environmental impact as compared to single-use.
North America will remain the largest region over the forecast period due to rising investment related to research and development of new biomolecules & mAbs, increasing prevalence of chronic diseases, and availability of developed healthcare infrastructure in the region.
|
Features of the Global Upstream Bioprocessing Market |
|
|
This report answers following key questions |
|
Q.1 What are some of the most promising potential, high-growth opportunities for the global upstream bioprocessing market by product (cell culture products, bioreactors/fermenters, filters, bags & containers, bioreactor accessories and others), workflow (cell culture, media preparation, and cell separation), use type (single-use and multi-use), mode (outsourced and in-house), and region (North America, Europe, Asia Pacific, and Rest of the World)? Q.2 Which segments will grow at a faster pace and why? Q.3 Which region will grow at a faster pace and why? Q.4 What are the key factors affecting market dynamics? What are the drivers and challenges of the global upstream bioprocessing market? Q.5 What are the business risks and threats to the global upstream bioprocessing market? Q.6 What are the emerging trends in this upstream bioprocessing market and the reasons behind them? Q.7 What are some changing demands of customers in this upstream bioprocessing market? Q.8 What are the new developments in this upstream bioprocessing market? Which companies are leading these developments? Q.9 Who are the major players in this upstream bioprocessing market? What strategic initiatives are being implemented by key players for business growth? Q.10 What are some of the competitive products and processes in this upstream bioprocessing market, and how big of a threat do they pose for loss of market share via material or product substitution? Q.11 What M&A activities did take place in the last five years in the global upstream bioprocessing market? |
Report Scope
| Key Features | Description |
| Base Year for Estimation | 2019 |
|
Trend Period (Actual Estimates) |
2014-2019 |
| Forecast Period | 2020-2025 |
| Pages | More than 150 |
| Market Representation / Units | Revenue in US $ Million |
| Report Coverage | Market Trends & Forecasts, Competitor Analysis, New Product Development, Company Expansion, Merger, Acquisitions & Joint Venture, and Company Profiling |
| Market Segments | Product (Cell Culture Products, Bioreactors/Fermenters, Filters, Bags & Containers, Bioreactor Accessories and Others), Workflow (Cell Culture, Media Preparation, and Cell Separation), Use Type (Single-Use and Multi-Use), and Mode (Outsourced and In-House) |
Regional Scope |
North America (USA, Mexico, and Canada), Europe (United Kingdom, Germany, and France), Asia (China, India, and Japan), and ROW (Brazil) |
| Customization | 10% Customization without Any Additional Cost |
Table of Contents
1. Executive Summary
7.2 Emerging Trends in the Global Upstream Bioprocessing Market
4.1 Global Upstream Bioprocessing Market by Region
4.2.1 Market by Product: Cell Culture Products, Bioreactors/Fermenters, Filters, Bags & Containers, Bioreactor Accessories and Others
4.2.2 Market by Workflow: Cell Culture, Media Preparation, and Cell Separation
4.2.3 Market by Use Type: Single-Use and Multi-Use
4.2.4 Market by Mode: Outsourced and In-House
4.2.5 The United States Upstream Bioprocessing Market
4.2.6 The Canadian Upstream Bioprocessing Market
4.2.7 The Mexican Upstream Bioprocessing Market
4.3.1 Market by Product: Cell Culture Products, Bioreactors/Fermenters, Filters, Bags & Containers, Bioreactor Accessories and Others
4.3.2 Market by Workflow: Cell Culture, Media Preparation, and Cell Separation
4.3.3 Market by Use Type: Single-Use and Multi-Use
4.3.4 Market by Mode: Outsourced and In-House
4.3.5 The Upstream Bioprocessing Market of United Kingdom
4.3.6 The German Upstream Bioprocessing Market
4.3.7 The French Upstream Bioprocessing Market
4.4.1 Market by Product: Cell Culture Products, Bioreactors/Fermenters, Filters, Bags & Containers, Bioreactor Accessories and Others
4.4.2 Market by Workflow: Cell Culture, Media Preparation, and Cell Separation
4.4.3 Market by Use Type: Single-Use and Multi-Use
4.4.4 Market by Mode: Outsourced and In-House
4.4.5 The Chinese Upstream Bioprocessing Market
4.4.6 The Indian Upstream Bioprocessing Market
4.4.7 The Japanese Upstream Bioprocessing Market
4.5.1 Market by Product: Cell Culture Products, Bioreactors/Fermenters, Filters, Bags & Containers, Bioreactor Accessories and Others
4.5.2 Market by Workflow: Cell Culture, Media Preparation, and Cell Separation
4.5.3 Market by Use Type: Single-Use and Multi-Use
4.5.4 Market by Mode: Outsourced and In-House
4.5.5 Brazilian Upstream Bioprocessing Market
7.1.1 Growth Opportunities for the Global Upstream Bioprocessing Market by Product
7.1.2 Growth Opportunities for the Global Upstream Bioprocessing Market by Workflow
7.1.3 Growth Opportunities for the Global Upstream Bioprocessing Market by Use Type
7.1.4 Growth Opportunities for the Global Upstream Bioprocessing Market by Mode
7.1.5 Growth Opportunities for the Global Upstream Bioprocessing Market by Region
Methodology
Lucintel has been in the business of market research and management consulting since 2000 and has published over 1000 market intelligence reports in various markets / applications and served over 1,000 clients worldwide. This study is a culmination of four months of full-time effort performed by Lucintel's analyst team. The analysts used the following sources for the creation and completion of this valuable report:
- In-depth interviews of the major players in this market
- Detailed secondary research from competitors’ financial statements and published data
- Extensive searches of published works, market, and database information pertaining to industry news, company press releases, and customer intentions
- A compilation of the experiences, judgments, and insights of Lucintel’s professionals, who have analyzed and tracked this market over the years.
Extensive research and interviews are conducted across the supply chain of this market to estimate market share, market size, trends, drivers, challenges, and forecasts. Below is a brief summary of the primary interviews that were conducted by job function for this report.
Thus, Lucintel compiles vast amounts of data from numerous sources, validates the integrity of that data, and performs a comprehensive analysis. Lucintel then organizes the data, its findings, and insights into a concise report designed to support the strategic decision-making process. The figure below is a graphical representation of Lucintel’s research process.
Buy Now
Choose a license that fits your team. Instant PDF delivery.
Prices exclude taxes. Instant delivery. Custom licensing available on request.
